Search

everythinglearnresearchcommunity

for

Search:↓

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Trichodysplasia spinulosa is a rare skin condition caused by a virus, treatable with antiviral medication.

Finasteride helps treat eyelid spasms.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

A neck lesion misdiagnosed as benign was later treated successfully with Mohs Micrographic Surgery.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

CO₂ laser treatment is fast and effective for some benign skin tumors with minimal side effects.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.